Viridian Therapeutics, Inc.VRDNNASDAQ
LOADING
|||
ROE: Returns Declining
Trending higher, below historical average, structural decline.
Left:
||||
Return on equity
Latest
-40.19%
↓ 113% below average
Average (9y)
311.92%
Historical baseline
Range
High:3887.73%
Low:-265.79%
CAGR
-10.5%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | -40.19% | +25.3% |
| 2023 | -53.78% | -63.6% |
| 2022 | -32.87% | +22.3% |
| 2021 | -42.30% | +54.1% |
| 2020 | -92.23% | +65.3% |
| 2019 | -265.79% | -317.3% |
| 2018 | -63.69% | +7.5% |
| 2017 | -68.84% | -101.8% |
| 2016 | 3887.73% | +3672.7% |
| 2015 | -108.82% | - |